1,721,263 research outputs found
Supplementary_file_A_-_The_feasibility,_reliability_and_validity_of_the_MSReactor_computerised_screening_tool_in_multiple_sclerosis – Supplemental material for The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis
No full textSupplemental material, Supplementary_file_A_-_The_feasibility,_reliability_and_validity_of_the_MSReactor_computerised_screening_tool_in_multiple_sclerosis for The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis by Daniel Merlo, David Darby, Tomas Kalincik, Helmut Butzkueven and Anneke van der Walt in Therapeutic Advances in Neurological Disorders</p
sj-docx-2-mso-10.1177_20552173221124023 - Supplemental material for Timely intervention, monitoring and education MATTERS in MS (TIME MATTERS in MS): Development of a globally applicable quality improvement tool
No full textSupplemental material, sj-docx-2-mso-10.1177_20552173221124023 for Timely intervention, monitoring and education MATTERS in MS (TIME MATTERS in MS): Development of a globally applicable quality improvement tool by Jeremy Hobart, Helmut Butzkueven, Jodi Haartsen, Tjalf Ziemssen and
Thirusha Lane, Gavin Giovannoni in Multiple Sclerosis Journal – Experimental, Translational and Clinical</p
sj-docx-1-mso-10.1177_20552173221124023 - Supplemental material for Timely intervention, monitoring and education MATTERS in MS (TIME MATTERS in MS): Development of a globally applicable quality improvement tool
No full textSupplemental material, sj-docx-1-mso-10.1177_20552173221124023 for Timely intervention, monitoring and education MATTERS in MS (TIME MATTERS in MS): Development of a globally applicable quality improvement tool by Jeremy Hobart, Helmut Butzkueven, Jodi Haartsen, Tjalf Ziemssen and
Thirusha Lane, Gavin Giovannoni in Multiple Sclerosis Journal – Experimental, Translational and Clinical</p
sj-docx-1-msj-10.1177_13524585231181578 – Supplemental material for Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585231181578 for Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis by Anna H He, Ali Manouchehrinia, Anna Glaser, Olga Ciccarelli, Helmut Butzkueven, Jan Hillert and Kyla Anne McKay in Multiple Sclerosis Journal</p
sj-docx-1-msj-10.1177_13524585231157206 – Supplemental material for Choroid plexus volume is enlarged in clinically isolated syndrome patients with optic neuritis
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585231157206 for Choroid plexus volume is enlarged in clinically isolated syndrome patients with optic neuritis by Samuel Klistorner, Anneke Van der Walt, Michael H Barnett, Helmut Butzkueven, Scott Kolbe, John Parratt, Con Yiannikas and Alexander Klistorner in Multiple Sclerosis Journal</p
Supplemental material for Early imaging predictors of longer term multiple sclerosis risk and severity in acute optic neuritis
No full textSupplemental Material for Early imaging predictors of longer term multiple sclerosis risk and severity in acute optic neuritis by Sanuji Gajamange Department of Medicine and Radiology, University of Melbourne, Australia Jim Stankovich Department of Neuroscience, Central Clinical School, Monash University, Australia Gary Egan Monash Biomedical Imaging, Monash University, Australia Trevor Kilpatrick The Florey Institute of Neuroscience and Mental Health, Australia Helmut Butzkueven, Joanne Fielding, Anneke van der Walt and Scott Kolbe in Multiple Sclerosis Journal – Experimental, Translational and Clinical</p
MSJ837706_supplementary_figures – Supplemental material for Functional neuroplasticity in response to cerebello-thalamic injury underpins the clinical presentation of tremor in multiple sclerosis
No full textSupplemental material, MSJ837706_supplementary_figures for Functional neuroplasticity in response to cerebello-thalamic injury underpins the clinical presentation of tremor in multiple sclerosis by Frederique MC Boonstra, Gustavo Noffs, Thushara Perera, Vilija G Jokubaitis, Adam P Vogel, Bradford A Moffat, Helmut Butzkueven, Andrew Evans, Anneke van der Walt and Scott C Kolbe in Multiple Sclerosis Journal</p
sj-docx-1-tan-10.1177_17562864211042458 – Supplemental material for No evidence for loss of natalizumab effectiveness with every-6-week dosing: a propensity score–matched comparison with every-4-week dosing in patients enrolled in the Tysabri Observational Program (TOP)
No full textSupplemental material, sj-docx-1-tan-10.1177_17562864211042458 for No evidence for loss of natalizumab effectiveness with every-6-week dosing: a propensity score–matched comparison with every-4-week dosing in patients enrolled in the Tysabri Observational Program (TOP) by Helmut Butzkueven, Ludwig Kappos, Tim Spelman, Maria Trojano, Heinz Wiendl, Ray Su, Shirley Liao, Robert Hyde, Stephanie Licata, Pei-Ran Ho and Nolan Campbell in Therapeutic Advances in Neurological Disorders</p
sj-docx-1-msj-10.1177_13524585221111677 – Supplemental material for Prediction of relapse activity when switching to cladribine for multiple sclerosis
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585221111677 for Prediction of relapse activity when switching to cladribine for multiple sclerosis by Michael Zhong, Anneke van der Walt, Mastura Monif, Suzanne Hodgkinson, Sara Eichau, Tomas Kalincik, Jeannette Lechner-Scott, Katherine Buzzard, Olga Skibina, Vincent Van Pesch, Ernest Butler, Julie Prevost, Marc Girard, Jiwon Oh, Helmut Butzkueven and Vilija Jokubaitis in Multiple Sclerosis Journal</p
sj-docx-1-tan-10.1177_17562864241239453 – Supplemental material for Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons
No full textSupplemental material, sj-docx-1-tan-10.1177_17562864241239453 for Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons by Nicholas Riley, Christopher Drudge, Morag Nelson, Anja Haltner, Michael Barnett, Simon Broadley, Helmut Butzkueven, Pamela McCombe, Anneke Van der Walt, Erin O. Y. Wong, Martin Merschhemke, Nicholas Adlard, Rob Walker and Imtiaz A. Samjoo in Therapeutic Advances in Neurological Disorders</p
- …
